Rocket Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $56.5M | $129.6M | $29.8M |
| FY2017 | $4.6M | $20.1M | $18.1M |
| FY2018 | $57.3M | $251.3M | $111.4M |
| FY2019 | $64.8M | $372.1M | $185.4M |
| FY2020 | $87.3M | $590.8M | $297.1M |
| FY2021 | $42.3M | $497.0M | $232.7M |
| FY2022 | $62.1M | $551.8M | $140.5M |
| FY2023 | $73.8M | $566.3M | $55.9M |
| FY2024 | $64.5M | $527.7M | $163.6M |
| FY2025 | $53.2M | $330.4M | $77.6M |